Concourse Financial Group Securities’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-202
Closed -$87K 989
2024
Q4
$87K Sell
202
-57
-22% -$25K ﹤0.01% 991
2024
Q3
$131K Sell
259
-7
-3% -$3.4K 0.01% 864
2024
Q2
$130K Sell
266
-13
-5% -$6.53K 0.01% 844
2024
Q1
$151K Sell
279
-585
-68% -$320K 0.01% 779
2023
Q4
$480K Sell
864
-94
-10% -$44.1K 0.03% 452
2023
Q3
$419K Buy
958
+19
+2% +$9.47K 0.03% 448
2023
Q2
$472K Buy
939
+277
+42% +$133K 0.04% 445
2023
Q1
$331K Sell
662
-73
-10% -$34.9K 0.03% 514
2022
Q4
$300K Sell
735
-69
-9% -$26.8K 0.02% 516
2022
Q3
$262K Buy
804
+155
+24% +$56.9K 0.02% 478
2022
Q2
$228K Buy
649
+145
+29% +$59.1K 0.02% 573
2022
Q1
$276K Sell
504
-270
-35% -$142K 0.02% 550
2021
Q4
$510K Buy
774
+98
+14% +$61.5K 0.03% 478
2021
Q3
$420K Buy
676
+57
+9% +$38.3K 0.03% 503
2021
Q2
$391K Sell
619
-222
-26% -$123K 0.02% 506
2021
Q1
$412K Sell
841
-1,180
-58% -$591K 0.03% 463
2020
Q4
$1.01M Buy
2,021
+426
+27% +$191K 0.08% 228
2020
Q3
$627K Buy
1,595
+132
+9% +$48.8K 0.05% 287
2020
Q2
$483K Buy
1,463
+1,328
+984% +$385K 0.05% 315
2020
Q1
$33K Sell
135
-3
-2% -$783 ﹤0.01% 1048
2019
Q4
$36K Buy
138
+115
+500% +$30.3K ﹤0.01% 1057
2019
Q3
$6K Sell
23
-122
-84% -$33.9K ﹤0.01% 1272
2019
Q2
$40K Buy
145
+23
+19% +$5.67K ﹤0.01% 945
2019
Q1
$27K Hold
122
﹤0.01% 1130
2018
Q4
$22K Hold
122
﹤0.01% 1105
2018
Q3
$30K Buy
+122
New +$29.6K 0.01% 720

Other funds holding IDXX

Concourse Financial Group Securities's IDXX Position: Q1 2025 in Review

Concourse Financial Group Securities sold out of Idexx Laboratories (IDXX) in Q1 2025, closing a stake of 202 shares — an estimated $87K sold.

Concourse Financial Group Securities first reported a position in IDXX in Q3 2018 and held it in 26 quarters. The position peaked at $1.01M in Q4 2020. 1,143 funds tracked by Wall St. Rank hold IDXX as of Q1 2025.

  • Concourse Financial Group Securities reported no remaining Idexx Laboratories position as of Q1 2025 after selling out during the quarter.
  • Concourse Financial Group Securities sold 202 Idexx Laboratories shares in Q1 2025, an estimated $87K.
  • Concourse Financial Group Securities first reported a position in Idexx Laboratories in Q3 2018 and held it in 26 quarters.
  • Concourse Financial Group Securities's Idexx Laboratories position peaked at $1.01M in Q4 2020.
  • 1,143 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2025.

Based on Concourse Financial Group Securities's 13F filing for Q1 2025.